Ondansetron Tablet, Orally Disintegrating
Product Images NDC 43063-870

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 43063-870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063870 Label (43063870)

Ondansetron ODT USP 8 mg orally disintegrating tablets packaging label from PD-Rx Pharmaceuticals, Inc., containing 4 tablets. The label includes NDC 43063-870-04, lot number B22E38, and expiration date 02/2024. It also has medication instructions in English and Spanish and a barcode with GTIN and serial numbers.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure of the active ingredient Ondansetron, showing its molecular arrangement including a fused indole ring and a methyl-substituted imidazole group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.